Glucagon-Like Peptide-1 analogs with long duration of action

Details for Australian Patent Application No. 2005203925 (hide)

Owner Theratechnologies Inc.

Inventors Peri, Krishna; Abran, Daniel

Agent Cullen & Co

Pub. Number AU-A-2005203925

PCT Pub. Number WO2005/066207

Priority 60/534,682 08.01.04 US; 60/570,073 12.05.04 US

Filing date 7 January 2005

Wipo publication date 21 July 2005

International Classifications

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066207 Priority application(s): WO2005/066207

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203930-Heteroaryl-ureas and their use as glucokinase activators

2005203924-Polypropylene modification for improved adhesion of polypropylenebased multilayer packaging film structure to vacuum deposited aluminum